News - Diabetes mellitus type 2
2012-06-02 06:21:21
CHESTERFIELD, Mo., June 2, 2012 /PRNewswire/ -- Reliv International (RELV) has incorporated a breakthrough ingredient into its patented, clinically proven GlucAffect(®) formula.
2012-06-02 08:13:21
A new study published online in the British Medical Journal (BMJ) has discovered a possible link between one popular type of diabetes drug and the risk of bladder cancer.
2012-05-24 02:28:31
RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
2012-05-22 06:25:26
BOSTON, May 22, 2012 /PRNewswire/ -- Rhythm announced today the results of a Phase 1b clinical trial of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis.
